TTrialPathMatch Me to Trials
← Back to trials
RecruitingIPFReflux

The Role of Laryngopharyngeal Reflux in IPF

Eligible age

40–95 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective of this study is to show that the Supraglottic Index (SGI) is an easily-collected index that accurately identifies the presence and severity of laryngopharyngeal reflux (LPF) in idiopathic pulmonary fibrosis (IPF).

Sponsor: National Jewish Health

You may qualify if…

  • ✓ Diagnosis of IPF
  • ✓ Age 40-95
  • ✓ Able to read, speak, and understand English
  • ✓ If subjects are currently taking medication for reflux or GERD, they much be on a stable does for at least 4 weeks prior to consent.

You may not qualify if…

  • ✕ Patients who do not meet all inclusion criteria
  • ✕ Pregnant females

Where it's recruiting

Colorado

Denver

Source: ClinicalTrials.gov · NCT03418350 · last updated 2024-11-14